Page last updated: 2024-09-05

cilengitide and Breast Cancer

cilengitide has been researched along with Breast Cancer in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chakravarti, A; Huebner, A; Ibrahim, A; Lautenschlaeger, T; Li, B; Meng, W; Peereboom, D; Perry, J; White, J1
Bianconi, D; Chillà, A; Dorda, A; Geetha, N; Poettler, M; Prager, GW; Redlich, K; Sykoutri, D; Unseld, M; Zielinski, CC1
Bomba, HN; Gu, Z; Hu, Q; Isaacson, AJ; Jiang, T; Lu, Y; Sun, W; Ye, Y1
Bäuerle, T; Berger, MR; Goodman, SL; Komljenovic, D; Merz, M; Semmler, W1
Bäuerle, T; Berger, MR; Bretschi, M; Komljenovic, D; Merz, M; Semmler, W1
Bäuerle, T; Bretschi, M; Cheng, C; Dimitrakopoulou-Strauss, A; Semmler, W; Strauss, LG; Witt, H1
Burke, PA; DeNardo, GL; DeNardo, SJ; Lamborn, KR; Matzku, S; Miers, LA1

Other Studies

7 other study(ies) available for cilengitide and Breast Cancer

ArticleYear
In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines.
    Radiation oncology (London, England), 2013, Oct-23, Volume: 8

    Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Female; Gene Expression Regulation, Neoplastic; Humans; Integrin beta Chains; Integrin beta3; Neoplasm Metastasis; Snake Venoms

2013
Effects of cilengitide in osteoclast maturation and behavior.
    Experimental cell research, 2015, Sep-10, Volume: 337, Issue:1

    Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Drug Screening Assays, Antitumor; Female; Humans; Integrin alpha Chains; Mice; Osteoclasts; Signal Transduction; Snake Venoms

2015
Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots.
    Nano letters, 2016, Feb-10, Volume: 16, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Membrane Permeability; Drug Delivery Systems; Endosomes; Gene Transfer Techniques; Humans; Hyaluronoglucosaminidase; Mice; Snake Venoms; TNF-Related Apoptosis-Inducing Ligand; Tumor Microenvironment; Xenograft Model Antitumor Assays

2016
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.
    International journal of cancer, 2011, May-15, Volume: 128, Issue:10

    Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Rats; Rats, Nude; Receptors, Vitronectin; Snake Venoms; Tomography, X-Ray Computed

2011
Cilengitide inhibits metastatic bone colonization in a nude rat model.
    Oncology reports, 2011, Volume: 26, Issue:4

    Topics: Animals; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Female; Humans; Magnetic Resonance Imaging; Neoplasm Invasiveness; Osteoclasts; Rats; Rats, Nude; Snake Venoms; Xenograft Model Antitumor Assays

2011
Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.
    Journal of cancer research and clinical oncology, 2013, Volume: 139, Issue:4

    Topics: Animals; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Integrin alphaVbeta3; Longitudinal Studies; Male; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Real-Time Polymerase Chain Reaction; Receptors, Vitronectin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Snake Venoms; Tumor Cells, Cultured; Tumor Microenvironment

2013
Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
    Cancer research, 2002, Aug-01, Volume: 62, Issue:15

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Apoptosis; Breast Neoplasms; Cell Division; Combined Modality Therapy; Endothelium, Vascular; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Radioimmunotherapy; Receptors, Vitronectin; Snake Venoms; Xenograft Model Antitumor Assays

2002